IDH1 c.392G>C ;(p.G131A)

Variant ID: 2-209113115-C-G

NM_005896.2(IDH1):c.392G>C;(p.G131A)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Molecularly Targeted Therapy in Acute Myeloid Leukemia: Current Treatment Landscape and Mechanisms of Response and Resistance.

Cancers
Lachowiez, Curtis A CA; DiNardo, Courtney D CD; Loghavi, Sanam S
Publication Date: 2023-03-06

Variant appearance in text: IDH1: G131A
PubMed Link: 36900407
Variant Present in the following documents:
  • Main text
  • cancers-15-01617.pdf
View BVdb publication page



Resistance to targeted therapies in acute myeloid leukemia.

Clinical & Experimental Metastasis
Mecklenbrauck, Rabea R; Heuser, Michael M
Publication Date: 2022-11-01

Variant appearance in text: IDH1: G131A
PubMed Link: 36318439
Variant Present in the following documents:
  • Main text
  • 10585_2022_Article_10189.pdf
View BVdb publication page



Molecular mechanisms mediating relapse following ivosidenib monotherapy in IDH1-mutant relapsed or refractory AML.

Blood Advances
Choe, Sung S; Wang, Hongfang H; DiNardo, Courtney D CD; Stein, Eytan M EM; de Botton, Stéphane S; Roboz, Gail J GJ; Altman, Jessica K JK; Mims, Alice S AS; Watts, Justin M JM; Pollyea, Daniel A DA; Fathi, Amir T AT; Tallman, Martin S MS; Kantarjian, Hagop M HM; Stone, Richard M RM; Quek, Lynn L; Konteatis, Zenon Z; Dang, Lenny L; Nicolay, Brandon B; Nejad, Parham P; Liu, Guowen G; Zhang, Vickie V; Liu, Hua H; Goldwasser, Meredith M; Liu, Wei W; Marks, Kevin K; Bowden, Chris C; Biller, Scott A SA; Attar, Eyal C EC; Wu, Bin B
Publication Date: 2020-05-12

Variant appearance in text: IDH1: G131A
PubMed Link: 32380538
Variant Present in the following documents:
  • Main text
View BVdb publication page